Contact

Address

No Building, Peter Maccallum Hospital

Phone

9656 1111

Email

gillian.duchesne@unimelb.edu.au

Credentials

Position

The Sir Peter Maccallum Department of Oncology
Education
Graduate Certificate in Health Economics
Monash University
Doctor of Medicine
University of Bristol
Bachelor of Medicine
University of Bristol
Bachelor of Surgery
University of Bristol
ORCID

0000-0002-2390-3451

Prof. Gill Duchesne

Honorary
The Sir Peter Maccallum Department of Oncology
109 Scholarly works
3 Projects

HIGHLIGHTS

  • 2021

    Journal article

    Navigating uncertainty: The implementation of Australian radiation therapy advanced practitioners.
    DOI: 10.1016/j.tipsro.2020.12.002
  • 2020

    Journal article

    Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
    DOI: 10.1016/S1470-2045(20)30456-3
  • 2020

    Journal article

    Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial
    DOI: 10.1111/his.14107
  • 2020

    Journal article

    Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial
    DOI: 10.1016/j.ijrobp.2019.11.415
  • 2020

    Conference Proceedings

    Is adjuvant radiotherapy now history? Implications of the RAVES and RADICALS trial on current practice
  • 2019

    Conference Proceedings

    A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP "RAVES" Trial
    DOI: 10.1016/j.ijrobp.2019.06.456
  • 2016

    Research Grant

    THE ROLE OF ADJUVANT ZOLEDRONIC ACID IN LOCALLY ADVANCED PROSTATE CANCER
Gill Duchesne

Latest Honours,
Awards and Fellowships

2020
Member of the Order of Australia
2020
Life member RANZCR
2016
Gold medallist RANZCR
2012
Life member TransTasman Radiation Oncology Research Group

RECENT SCHOLARLY WORKS

  • 2019

    Journal article

    Effective and well tolerated: where do these drugs fit now?
    DOI: 10.1016/S1470-2045(18)30901-X
  • 2019

    Journal article

    Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial
    DOI: 10.1016/S1470-2045(18)30757-5
  • 2019

    Journal article

    Extracting tumour prognostic factors from a diverse electronic record dataset in genito-urinary oncology
    DOI: 10.1016/j.ijmedinf.2018.10.008
  • 2018

    Conference Proceedings

    Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials
    DOI: 10.1016/j.ijrobp.2018.06.358

RECENT PROJECTS

  • 2010

    Research Grant

    Improving accuracy of Radiation Therapy for Bladder Cancer

  • Research Grant

    A clinical trial to determine the optimal timing of androgen deprivation in relapsed or non-curable prostate cancer